Allogene Therapeutics, Inc. (ALLO) Net Margin
- 2026-06-30: Net Margin -919.76%.
- 2024-03-31: Net Margin -295454.55%.
- 2023-12-31: Net Margin -408466.67%.
- 2023-09-30: Net Margin -283122.73%.
Complete source-backed net margin history.
- Available history
- 2021-03-31 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|
| 2026-06-30 | -919.76% |
|---|
| 2024-03-31 | -295454.55% |
|---|
| 2023-12-31 | -408466.67% |
|---|
| 2023-09-30 | -283122.73% |
|---|
| 2023-06-30 | -360145.45% |
|---|
| 2023-03-31 | -333226.67% |
|---|
| 2022-12-31 | -374134.62% |
|---|
| 2022-09-30 | -169689.80% |
|---|
| 2022-06-30 | -86961.63% |
|---|
| 2022-03-31 | -130901.64% |
|---|
| 2021-12-31 | 0.11% |
|---|
| 2021-09-30 | -159563.27% |
|---|
| 2021-06-30 | -161218.18% |
|---|
| 2021-03-31 | -86.10% |
|---|
Annual Net Margin
| Date | Net Margin |
|---|
| 2024-12-31 | -1170863.64% |
|---|
| 2023-12-31 | -344489.47% |
|---|
| 2022-12-31 | -218214.10% |
|---|
| 2021-12-31 | -159.57% |
|---|